Searched for
BIOTECH STOCK NEWS
Mutual funds added these 4 new stocks to their portfolios in May. Check detailsMutual funds introduced four new stocks into their portfolios in May, according to Prime Database disclosures. Afcom Holdings saw the highe...- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian benchmark indices ended higher after a volatile session, with late buying in heavyweight IT stocks lifting sentiment. Sensex gained ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- The ‘Inevitables’: Warren Buffett's framework for finding companies that will dominate for decadesWarren Buffett divided the investment universe into Inevitables, Highly Probables, and Impostors. The Inevitables are companies whose domin...
- Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
- Flipkart puts IPO on ice; Rapido's $240 million raiseFlipkart has hit pause on its IPO in a jittery market. This and more in today's ETtech Top 5.
- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- US stock market today: why Dow Jones crashing big while S&P 500 and Nasdaq are rising? Dow down by 200 points as oil surge, Fed jitters, and Big Tech earnings split market directionUS stock market today: Why Dow Jones Industrial Average falls while S&P 500 and Nasdaq Composite hold steady? US stock market today shows a...
- US stock market crashes today: why Dow Jones, S&P 500 and Nasdaq are down? Wall Street turns red as gold and silver prices also slipUS stock market crashes today: why Dow Jones, S&P 500 and Nasdaq are down today? Wall Street turns red as gold and silver prices also slip....
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record dateWindlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The ...
- Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forFour companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...
- Concord Biotech shares tumble 16% after weak Q3 earningsConcord Biotech shares fell 16% to Rs 1,777.7 after the company reported a 2.1% YoY decline in Q3 FY25 net profit to Rs 75.92 crore, despit...
- Add Rossari Biotech, target price Rs 885: ICICI SecuritiesRossari Biotech Ltd., incorporated in the year 2009, is a Small Cap company (having a market cap of Rs 4501.56 Crore) operating in Chemical...
- Rossari Biotech shares extend rally to 3rd day, jump 8%. Here’s whyShares of Rossari Biotech have risen over 11% in the last three trading sessions, following the company's Annual General Meeting on May 31,...
- COVID-19 vaccine review: PM Modi to visit Bharat Biotech facility in Hyderabad tomorrowPrime Minister Narendra Modi will be visiting vaccine maker Bharat Biotech's facility here on Saturday as part of his three-city tour to ta...
- A company called ISIS had a massive day on the stock marketAccording to Nasdaq, the stock price of ISIS Pharmaceuticals crossed above its 200-day moving average for the first time since early spring.
- A company called ISIS had a massive day on the stock marketISIS Pharmaceuticals, a $4.3 billion biotech firm surged 10% today, and it's up 43% in the last three months.
Load More
